Individual and system influences on waiting time for substance abuse treatment

Journal of Substance Abuse Treatment

Volumn 34, Issue 2, 2008, Pages 192-201

  Carr, Carey J A ^a   Xu, Jiangmin ^a   Redko, Cristina ^a   Lane, D Timothy ^a   Rapp, Richard C ^a   Goris, John ^b   Carlson, Robert G ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

^b Samaritan Behavioral Health   (United States)

Author keywords

Case management; Motivational interviewing; Substance abuse treatment; Waiting time

Indexed keywords

CANNABIS; COCAINE;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG DEPENDENCE TREATMENT; HEALTH SERVICE; HELP SEEKING BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; PATIENT REFERRAL; PRIORITY JOURNAL; SUBSTANCE ABUSE; THERAPY DELAY;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OHIO; PATIENT ADMISSION; SEVERITY OF ILLNESS INDEX; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; WAITING LISTS;

EID: 38549098291     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2007.03.005     Document Type: Article

References (47)

1. Adamson A.J., and Sellman J.D. The pattern of intravenous drug use and associated criminal activity in patients on a methadone treatment waiting list. Drug and Alcohol Review 17 (1998) 159-166
2. Addenbrooke W.M., and Rathod N.H. Relationship between waiting time and retention in treatment amongst substance abusers. Drug and Alcohol Dependence 26 (1990) 255-264
3. Alexander J.A., Nahra T.A., and Wheeler J.R.C. Managed care and access to substance abuse treatment services. Journal of Behavioral Health Services & Research 30 (2003) 161-175
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders-IV-TR. 4th ed. (2000), American Psychiatric Association, Washington, DC
5. American Society of Addiction Medicine. Patient placement criteria for the treatment for substance-related disorders. 2nd ed. (2001), American Society of Addiction Medicine, Chevy Chase, MD
6. Appel P.W., Ellison A.A., Jansky H.K., and Oldak R. Barriers to enrollment in drug abuse treatment and suggestions for reducing them: Opinions of drug injecting street outreach clients and other system stakeholders. American Journal of Drug and Alcohol Abuse 30 (2004) 129-153
7. Bell J., Caplehorn J.R.M., and McNeil D.R. The effect of intake procedures on performance in methadone maintenance. Addiction 89 (1994) 463-471
8. Best D., Noble A., Ridge G., Gossop M., Farrell M., and Strang J. The relative impact of waiting time and treatment entry on drug and alcohol abuse. Addiction Biology 7 (2002) 67-74
9. Brown B.S., Hickey J.E., Chung A.S., Craig R.D., and Jaffe J.H. The functioning of individuals on a drug abuse treatment waiting list. American Journal of Drug and Alcohol Abuse 1 (1989) 261-274
10. Carlson R.G. Ethnography and applied substance misuse research: Anthropological and cross-cultural factors. In: Miller W., and Carroll K. (Eds). A rethinking of substance abuse: What the science shows, and what we should do about it (2006), Guilford, New York 201-219
11. Chawdhary A., Sayre S.L., Green C., Schmitz J.M., Grabowski J., and Mooney M.E. Moderators of delay tolerance in treatment-seeking cocaine users. Addictive Behaviors 32 (2007) 370-376
12. Claus R.E., and Kindleberger L.R. Engaging substance abusers after centralized assessment: Predictors of treatment entry and dropout. Journal of Psychoactive Drugs 34 (2002) 25-31
13. Donovan D.M., Rosengren D.B., Downey L., Cox G.B., and Sloan K.L. Attrition prevention with individuals awaiting publicly funded drug treatment. Addiction 96 (2001) 1149-1160
14. Downey L., Rosengren D.B., and Donovan D.M. Gender, waitlists, and outcomes for public-sector drug treatment. Journal of Substance Abuse Treatment 25 (2003) 19-28
15. Ettner S.L., Huang D., Evans E., Ash D.R., Hardy M., and Jourabchi M. Benefit-cost in the California Treatment Outcome Project: Does substance abuse treatment "pay for itself"?. Health Services Research 41 (2006) 192-213
16. Farabee D., Leukefeld C.G., and Hays L. Accessing drug-abuse treatment: Perceptions of out of treatment injectors. Journal of Drug Issues 28 (1998) 381-394
17. Festinger D.S., Lamb R.J., Kountz M.R., Kirby K.C., and Marlowe D. Pretreatment dropout as a function of treatment delay and client variables. Addictive Behaviors 20 (1995) 111-115
18. French M.T. Brief Drug Abuse Treatment Cost Analysis Program (Brief DATCAP): Program version. 1st ed. (2002), University of Miami, Coral Gables, FL
19. French M.T., Dunlap L.J., Zarkin G.A., McGeary K.A., and McLellan A.T. A structured instrument for estimating the economic cost of drug abuse treatment: The Drug Abuse Treatment Cost Analysis Program (DATCAP). Journal of Substance Abuse Treatment 14 (1997) 445-455
20. Friedmann P.D., Lemon S.C., Stein M.D., and D'Aunno T.A. Accessibility of addiction treatment: Results from a national survey of outpatient substance abuse treatment organizations. Health Services Research 38 (2003) 887-903
21. Gardner L.I., Metsch L.R., Anderson-Mahoney P., Loughlin A.M., del Rio C., Strathdee S., et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS 19 (2005) 423-431
22. Heather N. Motivational interviewing: Is it all our clients need?. Addiction Research & Theory 13 (2005) 1-18
23. Hser Y., Maglione M., Polinsky M.L., and Anglin M.D. Predicting drug treatment entry among treatment-seeking individuals. Journal of Substance Abuse Treatment 15 (1998) 213-220
24. Hubbard R.L., Craddock S.G., and Anderson J. Overview of 5-year follow-up outcomes in the Drug Abuse Treatment Outcome Studies (DATOS). Journal of Substance Abuse Treatment 25 (2003) 125-134
25. Hunkeler E.M., Hung Y., Rice D.P., Weisner C., and Hu T. Alcohol consumption patterns and health care costs in an HMO. Drug and Alcohol Dependence 64 (2001) 181-190
26. Kaplan E.H., and Johri M. Treatment on demand: An operational model. Health Care Management Science 3 (2000) 171-183
27. Koenig L., Siegel J.M., Harwood H., Gilani J., Chen Y.J., Leahy P., et al. Economic benefits of substance abuse treatment: Findings from Cuyahoga County, Ohio. Journal of Substance Abuse Treatment 28 (2005) S41-S50
28. McCaughrin W.C., and Howard D.L. Variation in access to outpatient substance abuse treatment: Organizational factors and conceptual issues. Journal of Substance Abuse 8 (1996) 403-415
29. McCollister K.E., and French M.T. The relative contribution of outcome domains in the total economic benefit of addiction interventions: A review of first findings. Addiction 98 (2003) 1647-1659
30. McLellan A.T. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 9 (1992) 199-213
31. Palepu A., Tyndall M.W., Leon H., Muller J., O'Shaughnessy M.V., Schechter M.T., et al. Hospital utilization and cost in a cohort of injection drug users. Canadian Medical Association 165 (2001) 415-420
32. Pollini R.A., McCall L., Mehta S.H., Vlahov D., and Strathdee S.A. Non-fatal overdose and subsequent drug treatment among injection drug users. Drug and Alcohol Dependence 83 (2006) 104-110
33. Rapp R.C. Strengths-based case management: Enhancing treatment for persons with substance abuse problems. In: Saleebey D. (Ed). The strength perspective in social work practice (2006), Allyn and Bacon, Boston, MA 124-142
34. Rapp R.C., Siegal H.A., Li L., and Saha P. Predicting postprimary treatment services and drug use outcome: A multivariate analysis. American Journal of Drug and Alcohol Abuse 24 (1998) 603-615
35. Rapp, R. C., Xu, J., Carr, C. A., Lane, T., Redko, C., Wang, J., et al. (in press). Understanding treatment readiness in recently assessed, pre-treatment substance abusers. Substance Abuse.
36. Rapp R.C., Xu J., Carr C.A., Lane T., Wang J., and Carlson R.G. Treatment barriers identified by substance abusers assessed at a centralized intake unit. Journal of Substance Abuse Treatment 30 (2006) 227-235
37. Redko C., Rapp R.C., and Carlson R.G. Waiting time as a barrier to treatment entry: Perceptions of substance abusers. Journal of Drug Issues 4 (2006) 831-852
38. Rotstein D.L., and Alter D.A. Where does the waiting list begin? A short review of the dynamics and organization of modern waiting lists. Social Science & Medicine 62 (2006) 3157-3160
39. SAS Institute. SAS/STAT user's guide. Version 8 (1999), SAS Institute, Cary, NC
40. Schottenfeld R.S., O'Malley S., Abdul-Salaam K., and O'Connor P. Decline in intravenous drug use among treatment-seeking opiate users. Journal of Substance Abuse Treatment 10 (1993) 5-10
41. Schwartz R.P., Highfield D.A., Jaffe J.H., Brady J.V., Butler C.B., Rouse C.O., et al. A randomized controlled trial of interim methadone maintenance. Archives of General Psychiatry 63 (2006) 102-109
42. Siegal H.A., Rapp R.C., Kelliher C.W., Fisher J.H., Wagner J.H., and Cole P.A. The strengths perspective of case management: A promising inpatient substance abuse treatment enhancement. Journal of Psychoactive Drugs 27 (1995) 67-72
43. Simpson D., Joe G., and Brown B. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behavior 11 (1997) 294-307
44. Stark M.J., Campbell B.K., and Brinkerhoff C.V. "Hello, may we help you?" A study of attrition prevention at the time of the first phone contact with substance-abusing clients. American Journal of Drug and Alcohol Abuse 16 (1990) 67-76
45. Wenger L.D., and Rosenbaum M. Drug treatment on demand-Not. Journal of Psychoactive Drugs 26 (1994) 1-11
46. Xu, J., Wang, J., Rapp, R. C., & Carlson, R. G. (in press). The multidimensional structure of internal barriers to substance abuse treatment and its invariance across gender, ethnicity, and age. Journal of Drug Issues.
47. Zarkin G.A., Dunlap L.J., Hicks K.A., and Mamo D. Benefits and costs of methadone treatment: Results from a lifetime simulation model. Health Economics 14 (2005) 1133-1150